1. Mao JS, Dong DX, Zhang HY, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis. 1989;159:621–24.
2. Zhuang FC, Qian W, et al. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl). 2005;118:1851–856.
3. Zhuang FC, Mao ZA, Jiang LM, et al. Long term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2-strain) — A study on the result of 15 years’ follow up. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31:1332–335.
4. Shah N, Faridi MMA, Mitra M, et al. Review of long term immunogenicity and tolerability of live hepatitis A vaccine. Hum Vaccin Immunother. 2020 Apr 3;1–6
5. WHO position paper on hepatitis A vaccines — June, 2012. Weekly Epidemiological Record. 2012;87:261–76.